Back to Results
First PageMeta Content



Crescendo Biologics to attend 36th Annual J.P. Morgan Healthcare Conference 2018, San Francisco Cambridge, UK, 2 January 2018 – Crescendo Biologics Limited (Crescendo), the drug developer of novel, targeted T-cell enga
Add to Reading List

Document Date: 2018-01-02 07:03:43


Open Document

File Size: 273,14 KB

Share Result on Facebook
UPDATE